Literature DB >> 2115219

Canine mast cell tumors.

D A O'Keefe1.   

Abstract

Mast cell tumors (MCTs) are common in the dog, occurring most frequently in the skin and subcutaneous tissues. Their biologic behavior can be quite variable, with approximately 50% being malignant. Although clinical features and histologic grading can help determine the likelihood of malignancy, it is difficult to predict the biologic behavior of an individual tumor. Consequently, all MCTs should be considered potentially malignant. Wide surgical excision is the most common therapy for canine MCTs, although approximately 50% recur locally. Nonresectable or recurrent MCTs can be treated with radiation and/or chemotherapy. Chemotherapy is also used in the treatment of metastatic MCTs, and it may be helpful in preventing the recurrence and/or metastasis of undifferentiated tumors.

Entities:  

Mesh:

Year:  1990        PMID: 2115219     DOI: 10.1016/s0195-5616(90)50087-x

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  4 in total

1.  Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours.

Authors:  S Rodriguez; K Fadlalla; T Graham; B Tameru; C D Fermin; T Samuel
Journal:  J Comp Pathol       Date:  2012-01-30       Impact factor: 1.311

2.  Multivariate survival analysis of histological parameters and clinical presentation in canine cutaneous mast cell tumours.

Authors:  R Preziosi; G Sarli; M Paltrinieri
Journal:  Vet Res Commun       Date:  2006-12-29       Impact factor: 2.459

Review 3.  Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.

Authors:  Andrigo Barboza de Nardi; Rodrigo Dos Santos Horta; Carlos Eduardo Fonseca-Alves; Felipe Noleto de Paiva; Laís Calazans Menescal Linhares; Bruna Fernanda Firmo; Felipe Augusto Ruiz Sueiro; Krishna Duro de Oliveira; Silvia Vanessa Lourenço; Ricardo De Francisco Strefezzi; Carlos Henrique Maciel Brunner; Marcelo Monte Mor Rangel; Paulo Cesar Jark; Jorge Luiz Costa Castro; Rodrigo Ubukata; Karen Batschinski; Renata Afonso Sobral; Natália Oyafuso da Cruz; Adriana Tomoko Nishiya; Simone Crestoni Fernandes; Simone Carvalho Dos Santos Cunha; Daniel Guimarães Gerardi; Guilherme Sellera Godoy Challoub; Luiz Roberto Biondi; Renee Laufer-Amorim; Paulo Ricardo de Oliveira Paes; Gleidice Eunice Lavalle; Rafael Ricardo Huppes; Fabrizio Grandi; Carmen Helena de Carvalho Vasconcellos; Denner Santos Dos Anjos; Ângela Cristina Malheiros Luzo; Julia Maria Matera; Miluse Vozdova; Maria Lucia Zaidan Dagli
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

4.  Outcomes of adjunctive radiation therapy for the treatment of mast cell tumors in dogs and assessment of toxicity: A multicenter observational study of 300 dogs.

Authors:  Sarah L Mason; Charles Pittaway; Begona Pons Gil; Onne-Marju Russak; Katie Westlake; Davide Berlato; Jérôme Benoit; Joanna Morris; Jane Margaret Dobson
Journal:  J Vet Intern Med       Date:  2021-10-21       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.